Citation: | WANG Lingyun, ZHANG Yang, CHEN Yong, GE Yingqian, XU Zhihan, TAN Jingwen, WANG Lan, DU Lianjun, PAN Zilai, PAN Zhaocheng. Clinical Value of Applying Dual-energy CT Radio-mics Model to Evaluate Serosal Invasion of Advanced Gastric Cancer after Neoadjuvant Chemotherapy Treatment[J]. CT Theory and Applications, 2021, 30(5): 591-602. DOI: 10.15953/j.1004-4140.2021.30.05.07 |
[1] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:A Cancer Journal for Clinicians, 2018, 68(6):394-424. DOI: 10.3322/caac.21492.
|
[2] |
POH A R, O'DONOGHUE R J, ERNST M, et al. Mouse models for gastric cancer:Matching models to biological questions[J]. Journal of Gastroenterology and Hepatology, 2016, 31(7):1257-1272. DOI: 10.1111/jgh.13297.
|
[3] |
YCHOU M, BOIGE V, PIGNON J P, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma:An FNCLCC and FFCD multicenter phase Ⅲ trial[J]. Journal of Clinical Oncology, 2011, 29(13):1715-1721. DOI: 10.1200/jco.2010.33.0597.
|
[4] |
VAN HAGEN P, HULSHOF M, VAN LANSCHOT J, et al. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer[J]. The New England Journal of Medicine, 2012, 366:11. DOI: 10.1056/NEJMoa1112088.
|
[5] |
SIEWERT J R, BÖTTCHER K, STEIN H J, et al. Relevant prognostic factors in gastric cancer ten-year results of the german gastric cancer study[J]. Annals of Surgery, 1998, 228(4):449-461. DOI: 10.1097/00000658-199810000-00002.
|
[6] |
WANG H H, HUANG J Y, WANG Z N, et al. Macroscopic serosal classification as a prognostic index in radically resected stage pt3-pt4b gastric cancer[J]. Annals of Surgical Oncology, 2016, 23(1):149-155. DOI: 10.1245/s10434-015-4656-3.
|
[7] |
CHIAO-YUN C, WU D, KANG W, et al. Dynamic contrast-enhanced ultrasound of gastric cancer correlation with gastric cancer on computed tomography[J]. Radiology, 2007, 242(11):472-482. DOI: 10.1148/radiol.2422051557.
|
[8] |
ZHENG Z, YU Y, LU M, et al. Double contrast-enhanced ultrasonography for the preoperative evaluation of gastric cancer:A comparison to endoscopic ultrasonography with respect to histopathology[J]. American Journal of Surgery, 2011, 202(5):605-611. DOI:10.1016/j. amjsurg.2010.09.033.
|
[9] |
WANG J Y, HSIEH J S, HUANG Y S, et al. Endoscopic ultrasonography for preoperative locoregional staging and assessment of resectability in gastric cancer[J]. Clinical Imaging, 1998, 22(5):355-359. DOI: 10.1016/S0899-7071(98)00033-3.
|
[10] |
AHN H S, LEE H J, YOO M W, et al. Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer[J]. Journal of Surgical Oncology, 2009, 99(1):20-27. DOI: 10.1002/jso.21170.
|
[11] |
PARK S R, LEE J S, KIM C G, et al. Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer[J]. Cancer, 2008, 112(11):2368-2376. DOI: 10.1002/cncr.23483.
|
[12] |
YOSHIKAWA T, TANABE K, NISHIKAWA K, et al. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy:Cohort evaluation within a randomized phase Ⅱ study[J]. Annals of Surgical Oncology, 2014, 21(S3):S385-389. DOI: 10.1245/s10434-014-3615-8.
|
[13] |
GRASER A, JOHNSON T R, CHANDARANA H, et al. Dual energy CT:Preliminary observations and potential clinical applications in the abdomen[J]. European Radiology, 2009,19(1):13-23. DOI: 10.1007/s00330-008-1122-7.
|
[14] |
CHEN X, XU Y, DUAN J, et al. Correlation of iodine uptake and perfusion parameters between dual-energy CT imaging and first-pass dual-input perfusion CT in lung cancer[J]. Medicine (Baltimore), 2017, 96(28):e7479. DOI: 10.1097/MD.0000000000007479.
|
[15] |
MARCON J, GRASER A, HORST D, et al. Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-Correlation with microvascular density[J]. European Radiology, 2020, 30:1-10. DOI:10.1007/s00330-019- 06298-2.
|
[16] |
SATO K, MOROHASHI H, TSUSHIMA F, et al. Dual energy CT is useful for the prediction of mesenteric and lateral pelvic lymph node metastasis in rectal cancer[J]. Molecular and Clinical Oncology, 2019, 10(6):625-630. DOI: 10.3892/mco.2019.1834.
|
[17] |
TANG L, LI Z Y, LI Z W, et al. Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT:A comparison with pathological regression[J]. Clinical Radiology, 2015, 70(11):1198-204. DOI: 10.1016/j.crad.2015.06.083.
|
[18] |
AVANZO M, STANCANELLO J, EL NAQA I. Beyond imaging:The promise of radiomics[J]. Physicia Medica, 2017, 38:122-139. DOI: 10.1016/j.ejmp.2017.05.071.
|
[19] |
HUANG Y Q, LIANG C H, HE L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer[J]. Journal of Clinical Oncology, 2016, 34(18):2157-2164. DOI: 10.1200/JCO.2015.65.9128.
|
[20] |
XU X, ZHANG H L, LIU Q P, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma[J]. Journal of Hepatology, 2019, 70(6):1133-1144. DOI: 10.1016/j.jhep.2019.02.023.
|
[21] |
XU X, ZHANG H L, LIU Q P. Texture analysis in cerebral gliomas:A review of the literature[J]. American Journal of Neuroradiology, 2019, 40(6):928-934. DOI: 10.3174/ajnr.A6075.
|
[22] |
CUNNINGHAM D, ALLUM W H, STENNING S P, et al. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer[J]. The New England Journal of Medicine, 2006, 355(1):11-20. DOI: 10.1056/NEJMoa055531.
|
[23] |
SANO T, AIKO T. New Japanese classifications and treatment guidelines for gastric cancer:Revision concepts and major revised points[J]. Gastric Cancer. 2011, 14(2):97-100. DOI:10.1007/s10120-011-0040-6. PMID:21573921.
|
[24] |
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014(ver. 4)[J]. Gastric Cancer 2017, 20:1-19. https://doi.org/10.1007/s10120-016-0622-4.
|
[25] |
AMIN M B, GREENE F L, EDGE S B, et al. The Eighth Edition AJCC Cancer Staging Manual:Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging[J]. CA:A Cancer Journal for Clinicians, 2017, 67(2):93-99. DOI: 10.3322/caac.21388.
|
[26] |
GAO X, ZHANG Y, YUAN F, et al. Locally advanced gastric cancer:Total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy[J]. Journal of Cancer Research and Clinical Oncology, 2018, 144(11):2207-2218. DOI: 10.1007/s00432-018-2728-z.
|
[27] |
ALBRECHT M H, TROMMER J, WICHMANN J L, et al. Comprehensive comparison of virtual monoenergetic and linearly blended reconstruction techniques in third-generation dual-source dual-energy computed tomography angiography of the thorax and abdomen[J]. Investigative Radiology, 2016, 51(9):582-590. DOI: 10.1097/RLI.0000000000000272.
|
[28] |
SOFUE K, ITOH T, TAKAHASHI S, et al. Quantification of cisplatin using a modified 3-material decomposition algorithm at third-generation dual-source dual-energy computed tomography:An experimental study[J]. Investigative Radiology, 2018, 53(11):673-680. DOI: 10.1097/RLI.0000000000000491.
|
[29] |
HABERMANN C R, WEISS F, RIECKEN R, et al. Preoperative staging of gastric adenocarcinoma:Comparison of helical CT and endoscopic US[J]. Radiology, 2004, 230:465-471. DOI: 10.1148/radiol.2302020828.
|
[30] |
HASEGAWA S, YOSHIKAWA T, SHIRAI J, et al. A prospective validation study to diagnose serosal invasion and nodal metastases of gastric cancer by multidetector-row CT[J]. Annals of Surgical Oncology, 2013, 20(6):2016-2022. DOI: 10.1245/s10434-012-2817-1.
|
[31] |
WELS MG, LADES F, MUEHLBERG A, et al. General purpose radiomics for multi-modal clinical research[DB/OL]. Proceedings Volume 10950, Medical Imaging 2019. https://doi.org/10.1117/12.2511856.
|
[32] |
ZWANENBURG A, LEGER S, VALLIÈRESM, LÖCK S. Image biomarker standardization initiative[J]. ArXiv Prepr arXiv:161207003. 2019. DOI: 10.17195/candat.2016.08.1.
|
[33] |
HUANG Y, LIU Z, HE L, et al. Radiomics signature:A potential biomarker for the prediction of disease-free survival in early-stage (I or Ⅱ) non-small cell lung cancer[J]. Radiology, 2016, 281(3):947-957. DOI: 10.1148/radiol.2016152234.
|
[34] |
KIYABU M, LEICHMAN L, CHANDRASOMA. Effects of preoperative chemotherapy on gastric adenocarcinomas:A morphologic study of 25 cases[J]. Cancer, 1992, 70:2239-2245. DOI: 10.1002/1097-0142(19921101).
|
[35] |
KIM T U, KIM S, LEE J W, et al. MDCT features in the differentiation of T4a gastric cancer from less-advanced gastric cancer:Significance of the hyperattenuating serosa sign[J]. The British Journal of Radiology, 2013, 86(1029):20130290. DOI: 10.1259/bjr.20130290.
|
[36] |
LIU S, SHI H, JI C, et al. Preoperative CT texture analysis of gastric cancer:Correlations with postoperative TNM staging[J]. Clinical Radiology, 2018, 73(8):756. e1-756, e9. DOI: 10.1016/j.crad.2018.03.005.
|
[37] |
AGRAWAL M D, KULKARNI N M, HAHN P F, et al. Oncologic applications of dual energy CT in the abdomen[J]. Radiographics a Review Publication of the Radiological Society of North America Inc, 2014, 34(3):589. DOI: 10.1148/rg.343135041.
|
[38] |
JIANG C, YANG P, LEI J, et al. the application of iodine quantitative information obtained by dual-source dual-energy computed tomography on chemoradiotherapy effect monitoring for cervical cancer:A preliminary study[J]. Journal of Computer Assisted Tomography, 2017, 41(5):737-745. DOI: 10.1097/RCT.0000000000000603.
|
[39] |
BAXA J, MATOUSKOVA T, KRAKOROVA G, et al. Dual-phase dual-energy CT in patients treated with erlotinib for advanced non-small cell lung cancer:Possible benefits of iodine quantification in response assessment[J]. European Radiology, 2016, 26(8):2828-2836. DOI:10.1007/s00330- 015-4092-6.
|
[40] |
ZHANG L, TONG Y, ZHANG X, et al. Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth[J]. Drug Design Development and Therapy, 2015, 9:5851-5862. DOI: 10.2147/DDDT.S92943.
|
[41] |
Giganti F, Antunes S, Salerno A, et al. Gastric cancer:Texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker[J]. European Radiology, 2017, 27(5):1831-1839. DOI: 10.1007/s00330-016-4540-y.
|
[42] |
CHENG N, HSIEH C, LIAO C, et al. Prognostic value of tumor heterogeneity and SUVmax of pretreatment 18F-FDG PET/CT for salivary gland carcinoma with high-risk histology[J]. Clinical Nuclear Medicine, 2019, 44(5):351-358. DOI: 10.1097/RLU.0000000000002530.
|
[43] |
BURRELL R, MCGRANAHAN N, BARTEK J, et al. The causes and consequences of genetic heterogeneity in cancer evolution[J]. Nature, 2013, 501(7467):338-345. DOI: 10.1038/nature12625.
|
[44] |
BROCK C, HUANG S. Non-genetic heterogeneity:A mutation-independent driving force for the somatic evolution of tumours[J]. Nature Reviews Genetics, 2009, 10(5):336-342.
|
[45] |
YANG F, YOUNG P, GRIGSBY P. Predictive value of standardized intratumoral metabolic heterogeneity in locally advanced cervical cancer treated with chemoradiation[J]. International Journal of Gynecological Cancer Official Journal of the International Gynecological Cancer Society, 2016, 26(4):777.
|